Revascular Therapeutics' Series B - II Round

Revascular Therapeutics raised a round of funding on April 08, 2009.

ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based techn…

Articles about Revascular Therapeutics' Series B - II Round: